Growth hormone fails to deliver on tissue repair promises for adults

Growth hormone has failed to deliver tangible results for musculoskeletal tissue repair in adults, despite the theoretically favorable biological mechanisms underpinning its action. For decades, this molecule has been positioned as a cornerstone tool in regenerative medicine, particularly within biohacking and sports medicine circles, where the promise of accelerated muscle and bone recovery has generated considerable clinical enthusiasm. Yet the gap between mechanistic potential and real-world clinical outcomes persists as one of longevity medicine's great disappointments. Peter Attia, a leading voice in precision medicine, critically examines this disconnect, noting that neither controlled studies nor sustained clinical experience support the inflated expectations circulating in biological optimization communities. For readers committed to evidence-based intervention, this overvaluation of growth hormone underscores the necessity of rigorous scrutiny before adopting expensive tissue repair strategies.